Fundamentals

Valuation

Metric	Q3	Q4	Δ in %
EV/EBITDA	-9319.76	-1507.38	-16.00
Graham Fair Price	-30.79	1059.55	1530.98
PEG	230.55	-0.42	0.13
Price/Book	13.37	0.50	0.44
Price/Cash Flow	inf	0.00	129.16
Prices/Earnings	163.03	22.71	8.64
Price/Sales	-2.33	7.07	7.24
Price/FCF	inf	0.00	129.16
Naive Interpretation	member

01 - Valuation · Somewhat Weak

Fundamentals

Profitability

Metric	Q3	Q4	Δ in %
Gross Profit Margin	0.00	1.00	1.00
Operating Margin	-63.72	0.11	0.32
ROA	-55.00	< 0.005	< 0.005
ROE	0.01	< 0.005	-56.90
ROIC	< 0.005	< 0.005	-38.77
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q3	Q4	Δ in %
Debt QOQ	0.16	0.12	29.17
Dividends QOQ	0.00	0.00	0.00
EBIT QOQ	0.67	-0.56	-16.26
EPS QOQ	0.69	-0.55	-20.43
FCF QOQ	0.00	-1.00	-100.00
Revenue QOQ	0.17	0.21	25.33
Naive Interpretation	member

03 - Financial Growth · Weak

Fundamentals

Leverage & Liquidity

Metric	Q3	Q4	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	0.00	0.00	0.00
Days Sales Outstanding (DSO)	0.00	0.00	0.00
Inventory Turnover	0.00	0.00	0.00
Debt/Capitalization	0.76	0.66	-12.16
Quick Ratio	0.22	1.99	790.49
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q3	Q4	Δ in %
Book Value	2847.83	3002.09	5.42
Cash	7235.21	6378.14	-11.85
Capex	0.00	0.00	0.00
Free Cash Flow	9.78	0.00	inf
Revenue	174.53	213.56	22.36
Naive Interpretation	member

05 - Per Share Metrics · Positive

Fundamentals

Financial Health

Metric	Q3	Q4	Δ in %
Current Ratio	0.22	2.13	855.31
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	-38.88	624.72	1506.81
Naive Interpretation	Member

06 - Financial Health · Bad

Rating